Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201210068 Principal Investigator: Uy, Geoffrey
Title: Phase III, Multicenter, Randomized, Trial of CPX-351 (Cytarabine: Daunorubicin) Liposome Injection versus Cytarabine and Daunorubicin in Patients 60-75 Years of Age with Untreated High Risk (Secondary) AML
Phase: III Disease Site: Myeloid and Monocytic Leukemia
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
This study is designed to help us learn more about the investigational study drug, CPX-351, in elderly patients who are newly diagnosed with high risk (secondary) leukemia and have not received any treatment for the disease. Through this study, we plan to learn how safe CPX-351 is and how effective it is on the disease.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)